Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-001834
Filing Date
2025-02-27
Accepted
2025-02-27 17:15:54
Documents
110
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K iova-20241231x10k.htm   iXBRL 10-K 3500337
2 EX-10.30 iova-20241231xex10d30.htm EX-10.30 39192
3 EX-10.31 iova-20241231xex10d31.htm EX-10.31 23086
4 EX-10.42 iova-20241231xex10d42.htm EX-10.42 69434
5 EX-10.43 iova-20241231xex10d43.htm EX-10.43 85644
6 EX-10.54 iova-20241231xex10d54.htm EX-10.54 66192
7 EX-10.55 iova-20241231xex10d55.htm EX-10.55 35701
8 EX-19.1 iova-20241231xex19d1.htm EX-19.1 103825
9 EX-21.1 iova-20241231xex21d1.htm EX-21.1 2932
10 EX-23.1 iova-20241231xex23d1.htm EX-23.1 10656
11 EX-31.1 iova-20241231xex31d1.htm EX-31.1 11293
12 EX-31.2 iova-20241231xex31d2.htm EX-31.2 11146
13 EX-32.1 iova-20241231xex32d1.htm EX-32.1 6162
14 EX-32.2 iova-20241231xex32d2.htm EX-32.2 6362
15 EX-97.1 iova-20241231xex97d1.htm EX-97.1 24855
16 GRAPHIC iova-20241231x10k001.jpg GRAPHIC 71621
17 GRAPHIC iova-20241231xex19d1001.jpg GRAPHIC 18883
  Complete submission text file 0001558370-25-001834.txt   13839665

Data Files

Seq Description Document Type Size
18 EX-101.SCH iova-20241231.xsd EX-101.SCH 80917
19 EX-101.CAL iova-20241231_cal.xml EX-101.CAL 74484
20 EX-101.DEF iova-20241231_def.xml EX-101.DEF 342353
21 EX-101.LAB iova-20241231_lab.xml EX-101.LAB 616115
22 EX-101.PRE iova-20241231_pre.xml EX-101.PRE 538719
113 EXTRACTED XBRL INSTANCE DOCUMENT iova-20241231x10k_htm.xml XML 2349409
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36860 | Film No.: 25680685
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)